Alcidion — Q1 FY22 Earnings Presentation

5 slides from Alcidion's earnings presentation, Oct 26, 2021

Slide 1: Qtr'ly Update – Q1 FY22
For personal use only Qtr’ly Update – Q1 FY22 Continuing to build on solid foundations Kate Quirke, Group Managing Director 26 October 2021 COMMERCIAL IN CONFIDENCE 1
Slide 2: Q1 FY22 Financial Highlights
Q1 FY22 Financial Highlights For personal use only Continuing to build on solid foundations in FY22 $2.7M $17.2M $6.6M $3.4M $21.5M New Contracts Contracted Cash Receipts Cash Outflow Cash Revenue TCV in Q1 of new Contracted revenue Increase of Cash outflow in Q1; Strong Cash balance contracted reve
Slide 3: Growing Pipeline
Growing Pipeline For personal use only Pipeline continues to develop with several sizable opportunities now entering the contract negotiation stage which has provided a heightened optimism about the broader opportunity for Alcidion, particularly in the UK market. Increasingly seeing the potential to
Slide 4: Operational Highlights – Q1 + YTD (Oct)
Operational Highlights – Q1 + YTD (Oct) For personal use only • New contract with TCV of $1.8M over 3 years, won via competitive tender process Sydney • Use of Miya Precision in supporting virtual care of acute diverticulitis patients (likely to include other patients) via rpavirtual LHD along with
Slide 5: Questions
For personal use only Questions . . . Please enter your questions using the Zoom Q&A function COMMERCIAL IN CONFIDENCE 5